Nuo Therapeutics (AURX) 10-K/A 17 Apr 23 2022 FY Annual report (amended) Financial data

Document And Entity Information

Document And Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Apr. 10, 2023	Jun. 30, 2022
Document Information [Line Items]
Entity, Registrant Name	NUO THERAPEUTICS, INC.
Document, Type	10-K/A
Document, Annual Report	true
Document, Period End Date	Dec. 31, 2022
Document, Transition Report	false
Entity, File Number	000-28443
Current Fiscal Year End Date	--12-31
Document, Fiscal Period Focus	FY
Document, Fiscal Year Focus	2022
Entity, Incorporation, State or Country Code	DE
Entity, Tax Identification Number	23-3011702
Entity, Address, Address Line One	8285 El Rio, Suite 190
Entity, Address, City or Town	Houston
Entity, Address, State or Province	TX
Entity, Address, Postal Zip Code	77054
City Area Code	346
Local Phone Number	396-4770
Title of 12(g) Security	Common Stock, $0.0001 par value
Entity, Well-known Seasoned Issuer	No
Entity, Voluntary Filers	No
Entity, Current Reporting Status	Yes
Entity, Interactive Data, Current	Yes
Entity, Filer Category	Non-accelerated Filer
Entity, Small Business	true
Entity, Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity, Shell Company	false
Entity, Public Float			$ 17.8
Entity, Common Stock Shares, Outstanding		41,799,016
Amendment Description	This Amendment No. 1 to Form 10-K (the “Amendment”) is being filed solely to correct typographical errors in the year of the signature dates of the officer and directors in the original Form 10-K dated April 14, 2023 and as filed April 17, 2023 (the “Form 10-K”). In addition, this Amendment also includes Item 15 to hyperlink new certifications from the registrant’s principal executive and principal financial officer pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended. All other Items in the Form 10-K remain unchanged.
Auditor Name	Marcum LLP
Auditor Firm ID	688
Auditor Location	Houston, Texas
Amendment Flag	true
Entity, Central Index Key	0001091596